Alastair J. King

Abstract 6408: E3scan™ ligand binding assay platform for targeted protein degradation and PROTAC discovery

Ksenya Cohen Katsenelson, Luis Gonzalez, Gabriel Pallares, 2020 .

Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B-Raf-Driven Tumors.

Alastair J. King, Alex G. Waterson, A. Waterson, 2013, ACS medicinal chemistry letters.

Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E–mutated melanomas

Hong Wu, Johan Hansson, Alastair J. King, 2008, Molecular Cancer Therapeutics.